scispace - formally typeset
C

Claire Boursier-Neyret

Researcher at University of London

Publications -  15
Citations -  741

Claire Boursier-Neyret is an academic researcher from University of London. The author has contributed to research in topics: Liquid chromatography–mass spectrometry & Metabolomics. The author has an hindex of 10, co-authored 15 publications receiving 615 citations.

Papers
More filters
Journal ArticleDOI

Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery.

TL;DR: It is demonstrated that the UPLC/MS peak intensities of urine samples should respond linearly to variable sample dilution across the intensity range, and variance-stabilizing transformation and normalization are critical preprocessing steps that can benefit greatly metabolic information recovery from such data sets when widely applied chemometric methods are used.
Journal ArticleDOI

The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age.

TL;DR: This study provides an essential baseline for defining the “normal” metabolome and its main sources of variation in healthy volunteers and established reference human metabolome values in a large and well-defined population of French healthy volunteers.
Journal ArticleDOI

Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes

TL;DR: Permeability in the duodenum was two to three times lower than the jejunum for all compounds and so the concept of discrete "absorption windows" along the small intestine as suggested from some pharmacokinetic studies may be related to other effects such as pH and/or solubility.
Journal ArticleDOI

Simultaneous determination of ivabradine and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry

TL;DR: A rapid, selective, sensitive and reproducible liquid chromatographic method with tandem mass spectrometric detection has been developed and validated for the analysis of a new specific bradycardic agent, ivabradine and six potentially active metabolites in human plasma.